BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28676345)

  • 1. A six-month longitudinal evaluation significantly improves accuracy of predicting incipient Alzheimer's disease in mild cognitive impairment.
    Mubeen AM; Asaei A; Bachman AH; Sidtis JJ; Ardekani BA;
    J Neuroradiol; 2017 Oct; 44(6):381-387. PubMed ID: 28676345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
    Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
    Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.
    Ramírez J; Górriz JM; Ortiz A; Martínez-Murcia FJ; Segovia F; Salas-Gonzalez D; Castillo-Barnes D; Illán IA; Puntonet CG;
    J Neurosci Methods; 2018 May; 302():47-57. PubMed ID: 29242123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Progression From Mild Cognitive Impairment to Alzheimer's Disease Using Autoregressive Modelling of Longitudinal and Multimodal Biomarkers.
    Minhas S; Khanum A; Riaz F; Khan SA; Alvi A
    IEEE J Biomed Health Inform; 2018 May; 22(3):818-825. PubMed ID: 28534796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.
    Elahi S; Bachman AH; Lee SH; Sidtis JJ; Ardekani BA;
    J Alzheimers Dis; 2015; 45(3):921-31. PubMed ID: 25633676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
    Zhao L; Luo Y; Lew D; Liu W; Au L; Mok V; Shi L;
    Aging (Albany NY); 2019 Aug; 11(16):6217-6236. PubMed ID: 31467257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification.
    Korolev IO; Symonds LL; Bozoki AC;
    PLoS One; 2016; 11(2):e0138866. PubMed ID: 26901338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.